Literature DB >> 22582165

A complete compilation of matrix metalloproteinase expression in human malignant gliomas.

Carsten Hagemann1, Jelena Anacker, Ralf-Ingo Ernestus, Giles H Vince.   

Abstract

Glioblastomas are characterized by an aggressive local growth pattern, a marked degree of invasiveness and poor prognosis. Tumor invasiveness is facilitated by the increased activity of proteolytic enzymes which are involved in destruction of the extracellular matrix of the surrounding healthy brain tissue. Elevated levels of matrix metalloproteinases (MMPs) were found in glioblastoma (GBM) cell-lines, as well as in GBM biopsies as compared with low-grade astrocytoma (LGA) and normal brain samples, indicating a role in malignant progression. A careful review of the available literature revealed that both the expression and role of several of the 23 human MMP proteins is controversely discussed and for some there are no data available at all. We therefore screened a panel of 15 LGA and 15 GBM biopsy samples for those MMPs for which there is either no, very limited or even contradictory data available. Hence, this is the first complete compilation of the expression pattern of all 23 human MMPs in astrocytic tumors. This study will support a better understanding of the specific expression patterns and interaction of proteolytic enzymes in malignant human glioma and may provide additional starting points for targeted patient therapy.

Entities:  

Keywords:  Astrocytic tumor; Expression pattern; Glioblastoma cell-lines; Glioblastoma multiforme; Matrix metalloproteinase

Year:  2012        PMID: 22582165      PMCID: PMC3349915          DOI: 10.5306/wjco.v3.i5.67

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  133 in total

1.  Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.

Authors:  G Velasco; S Cal; A Merlos-Suárez; A A Ferrando; S Alvarez; A Nakano; J Arribas; C López-Otín
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  Overview of matrix metalloproteinase expression in cultured human cells.

Authors:  T A Giambernardi; G M Grant; G P Taylor; R J Hay; V M Maher; J J McCormick; R J Klebe
Journal:  Matrix Biol       Date:  1998-03       Impact factor: 11.583

Review 3.  Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

Authors:  P Borden; R A Heller
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1997       Impact factor: 1.807

Review 4.  Molecular mechanisms of glioma cell migration and invasion.

Authors:  Tim Demuth; Michael E Berens
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 5.  In vitro and in vivo models for the study of brain tumour invasion.

Authors:  G J Pilkington; R Bjerkvig; L De Ridder; P Kaaijk
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

6.  Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.

Authors:  Kyoko Komatsu; Yoko Nakanishi; Norimichi Nemoto; Tomokatsu Hori; Tatsuo Sawada; Makio Kobayashi
Journal:  Brain Tumor Pathol       Date:  2004       Impact factor: 3.298

7.  Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide.

Authors:  Nicholas A Pullen; Helen L Fillmore
Journal:  J Neurooncol       Date:  2009-07-21       Impact factor: 4.130

Review 8.  Proteases in brain tumour progression.

Authors:  N Levicar; R K Nuttall; T T Lah; R K Nutall
Journal:  Acta Neurochir (Wien)       Date:  2003-09       Impact factor: 2.216

9.  The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells.

Authors:  M Rossi; H K Rooprai; S L Maidment; G J Rucklidge; G J Pilkington
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  31 in total

1.  Mature brain-derived neurotrophic factor and its receptor TrkB are upregulated in human glioma tissues.

Authors:  Jing Xiong; L I Zhou; Yoon Lim; Miao Yang; Yu-Hong Zhu; Zhi-Wei Li; Deng-Li Fu; Xin-Fu Zhou
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

2.  Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.

Authors:  Zev A Binder; Amy Haseley Thorne; Spyridon Bakas; E Paul Wileyto; Michel Bilello; Hamed Akbari; Saima Rathore; Sung Min Ha; Logan Zhang; Cole J Ferguson; Sonika Dahiya; Wenya Linda Bi; David A Reardon; Ahmed Idbaih; Joerg Felsberg; Bettina Hentschel; Michael Weller; Stephen J Bagley; Jennifer J D Morrissette; MacLean P Nasrallah; Jianhui Ma; Ciro Zanca; Andrew M Scott; Laura Orellana; Christos Davatzikos; Frank B Furnari; Donald M O'Rourke
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

3.  Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.

Authors:  Sonia Aroui; Feten Najlaoui; Yassine Chtourou; Annie-Claire Meunier; Amel Laajimi; Abderraouf Kenani; Hamadi Fetoui
Journal:  Tumour Biol       Date:  2015-10-16

4.  Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.

Authors:  Feng Hu; Min-Chi Ku; Darko Markovic; Omar Dildar a Dzaye; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  Int J Cancer       Date:  2014-05-09       Impact factor: 7.396

5.  RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.

Authors:  Kant Sangpairoj; Pornpun Vivithanaporn; Somjai Apisawetakan; Sukumal Chongthammakun; Prasert Sobhon; Kulathida Chaithirayanon
Journal:  Cell Mol Neurobiol       Date:  2016-12-24       Impact factor: 5.046

6.  Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.

Authors:  Tanwarat Sanvoranart; Aungkura Supokawej; Pakpoom Kheolamai; Yaowalak U-Pratya; Niphon Poungvarin; Sith Sathornsumetee; Surapol Issaragrisil
Journal:  Tumour Biol       Date:  2016-09-20

Review 7.  The pathobiology of collagens in glioma.

Authors:  Leo S Payne; Paul H Huang
Journal:  Mol Cancer Res       Date:  2013-07-16       Impact factor: 5.852

8.  Pressure and Temperature Effects on the Activity and Structure of the Catalytic Domain of Human MT1-MMP.

Authors:  Elena Decaneto; Saba Suladze; Christopher Rosin; Martina Havenith; Wolfgang Lubitz; Roland Winter
Journal:  Biophys J       Date:  2015-12-01       Impact factor: 4.033

9.  ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.

Authors:  Jing Xiong; Li Zhou; Miao Yang; Yoon Lim; Yu-hong Zhu; Deng-li Fu; Zhi-wei Li; Jin-hua Zhong; Zhi-cheng Xiao; Xin-Fu Zhou
Journal:  Neuro Oncol       Date:  2013-04-10       Impact factor: 12.300

10.  Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro.

Authors:  Matthew Thomas Ferreira; Juliano Andreoli Miyake; Renata Nascimento Gomes; Fábio Feitoza; Pollyana Bulgarelli Stevannato; Andrew Silva da Cunha; Fernanda de Oliveira Serachi; Alexandros Theodoros Panagopoulos; Alison Colquhoun
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.